However, most human cancers with an intact LKB1 function still maintain low AMPK activity when exerting their tumorigenic properties [43-45], indicating that multiple mechanisms exist that depress AMPK activity in such cancer cells. This evidence concerns the gene PRKAA2 and cancer.